Hetzer Medical Indonesia Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 7.8M 24h volume). The key difference: Kian Santang Muliatama Tbk. is far larger — about 2.5× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 7.8M). Which is the better fit depends on your goals.
| MEDS | RGAS | |
|---|---|---|
Market Cap | 126.56B | 312.28B |
Volume | 319.74M | 7.8M |
Lot | 3.2M | 77.95K |
Turnover | 27.4B | 1.64B |
Average Price | 85.68 | 210.89 |
Value | 27.4B | 1.64B |
Indicative Equilibrium Price | 82 | 214 |
Indicative Equilibrium Volume | 12.79K | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →